Table 1.

Demographic and clinical manifestations of SLE patients

Number of Patients	890
Gender
Female	746 (88.7%)
Male	95 (11.3%)
Age (years) (mean ± SD)	33.8 ± 13.4
Ethnicity:
Caucasian	53.6%
Hispanic	12.0%
Asian	16.0%
Black	14.4%
Other	3.9%
Single/Married/Other	45.8%/40.2%/14%
Post secondary education	63.8%
Disease duration (months) (mean ± SD)	5.3 ± 4.2
Number of ACR criteria (mean ± SD)	4.9 ± 1.0
Cumulative ACR manifestations
Malar rash	36.9%
Discoid rash	12.0%
Photosensitivity	39.4%
Oral/nasopharyngeal ulcers	37.8%
Serositis	27.6%
Arthritis	74.0%
Renal disorder	28.1%
Neurological disorder	5.8%
Hematologic disorder	61.7%
Immunologic disorder	76.6%
Antinuclear antibody	96.6%
SLEDAI score (mean ± SD)	5.5 ± 5.6
SLICC/ACR damage index score (mean ± SD)	0.37 ± 0.81
Medications
Corticosteroids	68.5%
Antimalarials	64.4%
Immunosuppressants	37.5%
ASA	14.25%
Antidepressants	10.5%
Anticonvulsants	4.7%
Warfarin	3.0%
Antipsychotics	0.6%